Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 262

    1.

    High-Level Expression of S100A4 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Gastric Cancer.

    Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.

    Ann Surg Oncol. 2009 Oct 10. [Epub ahead of print]PMID: 19820999 [PubMed - as supplied by publisher]Related articles

    2.

    Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.

    Kim TH, Kim HI, Soung YH, Shaw LA, Chung J.

    Mol Cancer Res. 2009 Oct;7(10):1605-12. Epub 2009 Oct 6.PMID: 19808905 [PubMed - in process]Related articles

    3.

    RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.

    Tabata T, Tsukamoto N, Fooladi AA, Yamanaka S, Furukawa T, Ishida M, Sato D, Gu Z, Nagase H, Egawa S, Sunamura M, Horii A.

    Biochem Biophys Res Commun. 2009 Dec 18;390(3):475-80. Epub 2009 Sep 30.PMID: 19799859 [PubMed - in process]Related articles

    4.

    Opposite roles of metastasin (S100A4) in two potentially tumoricidal mechanisms involving human lymphocyte protein Tag7 and Hsp70.

    Dukhanina EA, Kabanova OD, Lukyanova TI, Shatalov YV, Yashin DV, Romanova EA, Gnuchev NV, Galkin AV, Georgiev GP, Sashchenko LP.

    Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13963-7. Epub 2009 Aug 3.PMID: 19666596 [PubMed - indexed for MEDLINE]Related articles

    5.

    Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.

    Kim JH, Kim CN, Kim SY, Lee JS, Cho D, Kim JW, Yoon SY.

    Oncol Rep. 2009 Jul;22(1):41-7.PMID: 19513503 [PubMed - indexed for MEDLINE]Related articles

    6.

    S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.

    Xie R, Schlumbrecht MP, Shipley GL, Xie S, Bassett RL Jr, Broaddus RR.

    Lab Invest. 2009 Aug;89(8):937-47. Epub 2009 Jun 8.PMID: 19506550 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma.

    Bandiera A, Melloni G, Freschi M, Giovanardi M, Carretta A, Borri A, Ciriaco P, Zannini P.

    World J Surg. 2009 Jul;33(7):1414-20.PMID: 19365673 [PubMed - indexed for MEDLINE]Related articles

    8.

    Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.

    Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B.

    Tumour Biol. 2009;30(1):15-25. Epub 2009 Feb 5.PMID: 19194111 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Effect of cobalt chloride on S100A4 expression in human gastric cancer cell BGC823]

    Hua J, Fu H, Zhang RX, Chen DQ, Yan Y, Chen FJ, Sun KL, Sun XJ.

    Yi Chuan. 2008 Dec;30(12):1563-6. Chinese. PMID: 19073570 [PubMed - indexed for MEDLINE]Related articles

    10.

    Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.

    Sherbet GV.

    Cancer Lett. 2009 Jul 18;280(1):15-30. Epub 2008 Dec 6. Review.PMID: 19059703 [PubMed - indexed for MEDLINE]Related articles

    11.

    Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.

    Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL.

    J Biol Chem. 2009 Jan 16;284(3):1484-94. Epub 2008 Nov 14.PMID: 19011242 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.

    Dokun OY, Florl AR, Seifert HH, Wolff I, Schulz WA.

    Int J Cancer. 2008 Dec 15;123(12):2798-807.PMID: 18803290 [PubMed - indexed for MEDLINE]Related articles

    13.

    S100A4 overexpression proves to be independent marker for breast cancer progression.

    Ismail NI, Kaur G, Hashim H, Hassan MS.

    Cancer Cell Int. 2008 Sep 5;8:12.PMID: 18771601 [PubMed - in process]Related articlesFree article

    14.

    [Functions of protein MTS1 (S100A4) in normal and tumor cells]

    Koshelev IuA, Georgiev GP, Kibardin AV.

    Genetika. 2008 Feb;44(2):149-62. Review. Russian. PMID: 18619032 [PubMed - indexed for MEDLINE]Related articles

    15.

    Activation of NF-kappaB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes.

    Boye K, Grotterød I, Aasheim HC, Hovig E, Maelandsmo GM.

    Int J Cancer. 2008 Sep 15;123(6):1301-10.PMID: 18548584 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.

    Tajeddine N, Louis M, Vermylen C, Gala JL, Tombal B, Gailly P.

    Leuk Lymphoma. 2008 Jun;49(6):1123-31.PMID: 18452107 [PubMed - indexed for MEDLINE]Related articles

    17.

    Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer.

    Matsumoto K, Irie A, Satoh T, Ishii J, Iwabuchi K, Iwamura M, Egawa S, Baba S.

    Urology. 2007 Sep;70(3):602-7. Epub 2007 Aug 3.PMID: 17688917 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hypomethylation-induced expression of S100A4 in endometrial carcinoma.

    Xie R, Loose DS, Shipley GL, Xie S, Bassett RL Jr, Broaddus RR.

    Mod Pathol. 2007 Oct;20(10):1045-54. Epub 2007 Aug 3.PMID: 17673926 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

    Mahon PC, Baril P, Bhakta V, Chelala C, Caulee K, Harada T, Lemoine NR.

    Cancer Res. 2007 Jul 15;67(14):6786-95.PMID: 17638890 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.

    Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, Babu MS, Chen CN, Lee PH, Chang KJ, Kuo ML.

    J Cell Sci. 2007 Jun 15;120(Pt 12):2053-65.PMID: 17550972 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...